| Literature DB >> 30962864 |
Bing Fu1, Qinghong Zeng1, Zhaoting Zhang1, Mingyue Qian1, Jiechun Chen1, Wanli Dong2, Min Li1.
Abstract
Green tea is one of the most beverages with antioxidants and nutrients. As one of the major components of green tea, (-)-epicatechin gallate (ECG) was evaluated for its antioxidative properties in the present study. Cell proliferation assay, tube formation, cell migration, apoptosis, and autophagy were performed in human brain microvascular endothelial cells (HBMVECs) after oxygen-glucose deprivation/reoxygenation (OGD/R) to investigate potential anti-ischemia/reperfusion injury properties of ECG in vitro. Markers of oxidative stress as ROS, LDH, MDA, and SOD were further assayed in our study. Data indicated that ECG could affect neovascularization and promote cell proliferation, tube formation, and cell migration while inhibiting apoptosis and autophagy through affecting VEGF, Bcl-2, BAX, LC3B, caspase 3, mTOR, and Beclin-1 expression. All the data suggested that ECG may be protective for the brain against ischemia/reperfusion injury by promoting neovascularization, alleviating apoptosis and autophagy, and promoting cell proliferation in HBMVECs of OGD/R.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30962864 PMCID: PMC6431361 DOI: 10.1155/2019/7824684
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Effect of ECG/EGCG on cell viability, apoptosis, and autophagy in HBMVECs of OGD/R. Chemical structures of ECG and EGCG are shown in (a). Cell viability was assayed by CCK-8 when HBMVECs were cultured in glucose-free culture and oxygen deprivation of 0.5% O2 + 5% CO2 + 94.5% N2 for 2 h, 4 h, 8 h, or 12 h and then reoxygenated for 12 or 24 h in normal medium (b). Cell viability of HBMVECs treated with 0.5, 1, 2, and 4 μM of ECG/EGCG in OGD/R measured by CCK-8 (c). Effect of ECG/EGCG on apoptosis induced by OGD/R, measured by flow cytometry, was explored (d and e). Autophagy was also observed using electron microscopy (f). Data was given as mean ± SD, n = 6. ∗ P < 0.05 and ∗∗ P < 0.01 compared with control, # P < 0.05 and ## P < 0.01 versus cells after OGD/R treatment with solvent (OGD/R or solvent control group).
Primers sequences, size of the amplification product, and NCBI reference sequence.
| Gene | Sequence | AMPL. size | NCBI ref. seq. | |
|---|---|---|---|---|
| GAPDH | Fw: | 5′- GGAGCGAGATCCCTCCAAAAT -3′ | 197 bp | NM_001256799 |
| Rev: | 5′- GGCTGTTGTCATACTTCTCATGG -3′ | |||
| VEGF | Fw: | 5′- AGGGCAGAATCATCACGAAGT -3′ | 75 bp | NM_001171627 |
| Rev: | 5′- AGGGTCTCGATTGGATGGCA -3′ | |||
| Bcl-2 | Fw: | 5′- GGTGGGGTCATGTGTGTGG-3′ | 89 bp | NM_000657 |
| Rev: | 5′- CGGTTCAGGTACTCAGTCATCC-3′ | |||
| BAX | Fw: | 5′- CCCGAGAGGTCTTTTTCCGAG-3′ | 155 bp | NM_138763 |
| Rev: | 5′- CCAGCCCATGATGGTTCTGAT-3′ | |||
| LC3B | Fw: | 5′- GATGTCCGACTTATTCGAGAGC-3′ | 167 bp | NM_022818 |
| Rev: | 5′- TTGAGCTGTAAGCGCCTTCTA-3′ | |||
| Caspase 3 | Fw: | 5′- CATGGAAGCGAATCAATGGACT-3′ | 139 bp | NM_004346 |
| Rev: | 5′- CTGTACCAGACCGAGATGTCA-3′ | |||
| mTOR | Fw: | 5′- ATGCTTGGAACCGGACCTG-3′ | 173 bp | NM_004958 |
| Rev: | 5′- TCTTGACTCATCTCTCGGAGTT-3′ | |||
| Beclin-1 | Fw: | 5′- CCATGCAGGTGAGCTTCGT-3′ | 215 bp | NM_003766 |
| Rev: | 5′- GAATCTGCGAGAGACACCATC-3′ | |||
Fw = forward; Rev = reverse.
Figure 2ECG affected ROS, LDH, MDA, and SOD in HBMVECs after OGD/R. Levels of ROS (a) and MDA (c), SOD activity (d) in cells and LHD releasing level (b) were detected using assay kits correspondingly. Data was given as mean ± SD, n = 6. ∗ P < 0.05 and ∗∗ P < 0.01 compared with control, # P < 0.05 and ## P < 0.01 versus cells after OGD/R treatment with solvent (OGD/R or solvent control group).
Figure 3ECG prompted migration and tube formation of HBMVECs after OGD/R. Cell migration of HBMVECs after OGD/R and treated with ECG was assayed using the Transwell method (a), and migrating cells were stained with crystal violet and measured at 570 nm for quantitative analysis (b). Tube formation of HBMVECs after OGD/R and treatment with ECG was performed (c), and tubes were quantified as analysis branch points as indicated by white arrows using ImageJ software (d). Data was given as mean ± SD, n = 6. ∗ P < 0.05 and ∗∗ P < 0.01 compared with control, # P < 0.05 and ## P < 0.01 versus cells after OGD/R treatment with solvent (OGD/R or solvent control group).
Figure 4The effect of ECG on mRNA and protein expression of VEGF, Bcl-2, BAX, LC3B, Caspase 3, mTOR, and Beclin-1 in HBMVEs after OGD/R. (a), (c), (e), (g), (i), (k), and (m) represent relative mRNA expression of VEGF, Bcl-2, BAX, LC3B, Caspase 3, mTOR, and Beclin-1 measured by qPCR. Protein expression of VEGF, Bcl-2, BAX, LC3B, Caspase 3, mTOR, and Beclin-1 determined by western blotting is shown in (b), (d), (f), (h), (j), (l), and (n) correspondingly. Data was given as mean ± SD, n = 6. ∗ P < 0.05 and ∗∗ P < 0.01 compared with control, # P < 0.05 and ## P < 0.01 versus cells after OGD/R treatment with solvent (OGD/R or solvent control group).